Mediolanum International Funds Ltd Has $4.62 Million Stock Holdings in Danaher Corporation (NYSE:DHR)

Mediolanum International Funds Ltd lifted its position in shares of Danaher Corporation (NYSE:DHR) by 41.4% during the 1st quarter, HoldingsChannel.com reports. The firm owned 22,459 shares of the conglomerate’s stock after buying an additional 6,574 shares during the quarter. Mediolanum International Funds Ltd’s holdings in Danaher were worth $4,623,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. GHP Investment Advisors Inc. grew its holdings in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 99 shares during the last quarter. Heck Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter valued at $27,000. Sierra Ocean LLC lifted its holdings in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 76 shares during the period. Smallwood Wealth Investment Management LLC bought a new stake in shares of Danaher in the first quarter worth $31,000. Finally, Hurley Capital LLC bought a new stake in shares of Danaher in the fourth quarter worth $34,000. 79.05% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts recently issued reports on DHR shares. Robert W. Baird raised their target price on Danaher from $225.00 to $226.00 and gave the stock an “outperform” rating in a research report on Friday, July 18th. Deutsche Bank Aktiengesellschaft decreased their price target on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. JPMorgan Chase & Co. lowered their price objective on Danaher from $280.00 to $260.00 and set an “overweight” rating for the company in a research report on Tuesday, April 22nd. Citigroup reiterated a “buy” rating on shares of Danaher in a report on Monday, April 7th. Finally, Barclays reissued an “overweight” rating and set a $225.00 target price (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Three equities research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $247.61.

Insider Activity at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president directly owned 15,179 shares of the company’s stock, valued at $3,005,442. The trade was a 51.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the business’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman owned 3,105,808 shares in the company, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.20% of the stock is owned by insiders.

Danaher Price Performance

Shares of NYSE DHR opened at $205.60 on Monday. The firm has a market capitalization of $147.22 billion, a P/E ratio of 43.74, a P/E/G ratio of 2.86 and a beta of 0.77. The firm’s 50-day moving average price is $196.38 and its 200-day moving average price is $203.44. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The business had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. During the same period in the previous year, the company posted $1.72 EPS. The firm’s revenue was up 3.4% compared to the same quarter last year. Equities research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, July 25th. Investors of record on Friday, June 27th were given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. Danaher’s payout ratio is 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.